	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S96-PMC5804559	PMC5804559	10/2017	S96-PMC5804559	['caption (table-wrap): table 4:\n\nfunctional annotation clustering (fac) as performed in davidannotation categorytermenrichment scoregeneflybase Gene idfunction p -value of anovasignificance of anovainterproimmunoglobulin-like Domain/fold11.42meshfbgn0051004ig fold0.000611***ppnfbgn0003137ig Domain, Extracellular Matrix structural constituent0.0101*interpro/go_term_bp_direct/goterm_mf_directproteolysis, peptidase6.16jon65aifbgn0035667serine-type endopeptidase, proteolysis0.00293**mp1fbgn0027930serine-type endopeptidase, Proteolysis0.00187**thetatryfbgn0011555digestive enzyme with serine-type peptidase activity1.68e-08***zetatryfbgn0011556digestive enzyme with serine-type peptidase activity0.000488***decayfbgn0028381cysteine-type endopeptidase activity, caspase0.00188**dammfbgn0033659cysteine-type endopeptidase activity, caspase6.79e-06***alphatryfbgn0003863serine-type endopeptidase, Proteolysis5.69e-05***ser7fbgn0019929serine-type endopeptidase, Proteolysis1.51e-12***ser6fbgn0011834serine-type endopeptidase, Proteolysis5.17e-03**Swimfbgn0034709Polysaccharide binding, cysteine-type peptidase activity, Proteolysis1.35e-02*jon74efbgn0023197serine-type endopeptidase, Proteolysis1.58e-03**pshfbgn0030926peptidase and serine-type endopeptidase activity, Defense response4.41e-08***jon65aivfbgn0250815serine-type endopeptidase, Proteolysis1.74e-04***jon65aiiifbgn0035665serine-type endopeptidase, Proteolysis6.77e-05***ance-4fbgn0033366peptidase6.97e-04***ancefbgn0012037peptidyl-dipeptidase activity6.97e-04***jon25biifbgn0031654serine-type endopeptidase, Proteolysis8.62e-04***goerm_bp_direct/interpro/goterm_mf_directg-protein-coupled receptor signalling, Rhodopsin-Like6.02rh3fbgn0003249g-protein coupled Photoreceptor activity3.73e-03**akhrfbgn0025595ccarbohydrate, Lipid and Tryglyceride Homeostasis1.88e-09***rh2fbgn0003248g-protein coupled Photoreceptor activity4.65e-02*galphasfbgn0001123signal transduction, chemical Synaptic Transmission1.07e-11***Ninaefbgn0002940G-protein coupled Photoreceptor activity, Rhodopsin-Like2.80e-05***ggamma1fbgn0004921g-Protein, Gamma Subunit, signal transducer activity4.16e-05***Gbeta76Cfbgn0004623G-protein coupled Photoreceptor activity2.71e-02*rh4fbgn0003250g-protein coupled Photoreceptor activity1.83e-03**goterm_mf_direct/goterm_bp_directfatty Acid elongation3.49eloffbgn0037762fatty Acid elongase4.60e-05***goterm_mf_directneuropeptide hormone activity/binding3.35nplp2fbgn0040813neuropeptide Signaling, Humoral Immune Response1.39e-02*nplp3fbgn0042201neuropeptide hormone activity, neuropeptide signaling3.45e-01nsneb-cgpfbgn0083167hormone activity, Regulation of growth3.72e-02*goterm_mf/cc/bp_directcalcium-dependent Phospholipid binding2.72anxb9fbgn0000083calcium Ion binding, calcium-dependent Phospholipid binding7.69e-03**gpterm_mp_direct, interpro, cog_ontologycalcium Ion binding, signal transduction, ef-hand Domain2.5calsfbgn0039928calcium Ion binding, chemical Synaptic Transmission2.29e-02*gelfbgn0010225actin binding, Calcium Ion binding1.52e-03**Scp2Fbgn0020907Calcium Ion binding3.43e-02*Scp1Fbgn0020908Calcium Ion binding8.74e-02.mlc2fbgn0002773calcium Ion binding3.33e-04***zasp52fbgn0265991muscle development3.91e-08***lpr1fbgn0066101uptake of neutral Lipids from circulation, Calcium Ion binding4.93e-01nsmlc1fbgn0002772calcium Ion binding, myosin3.91e-04***upfbgn0004169calcium Ion binding, Calcium Ion homeostatis, Muscle Morphogenesis3.26e-04***Tpnc73Ffbgn0010424Calcium Ion binding3.01e-10***Gpo-1fbgn0022160glycerol-3-Phosphate dehydrogenase activity, Calcium Ion binding0.000209***interpro, goterm_mf/bp/cc_directfatty Acyl-Coa reductase, Peroxisome2.47watfbgn0039620long-chain-fatty-acyl-coa reductase activity, oxidation-reduction process1.21e-06***spatfbgn0014031amino transferase activity, glyoxylate Catabolic Process, proxisome2.02e-02*catfbgn0000261catalase, antioxidant activity and Ros Metabolic Process1.15e-02*urofbgn0003961urate oxidase activity, Oxidation-reduction process, Peroxisome1.96e-02*acox57d-dfbgn0034629acyl-coa dehydrogenase activity, Fatty Acid Beta-Oxidation, Peroxisome4.63e-05***goterm_mf/bp/cc_direct, interprooxidation−reduction, haeme binding, Iron Ion binding, Cytochrome p4502.2menfbgn0002719malic oxidoreductase, determination of Adult Lifespan5.16e-04***cyp6a23fbgn0033978cytochrome p450, Heme and Iron Ion binding, oxidation-reduction process4.93e-01nscyp4p1fbgn0015037cytochrome P450, Heme and Iron Ion binding, oxidation-reduction process7.98e-02.cprfbgn0015623nadph-hemoprotein reductase activity, Oxidation-reduction process2.27e-04***cyt-b5-rfbgn0000406heme binding, oxidoreductase activity, Lipid Metabolic Process2.69e-04***Antdhfbgn0026268Oxidoreductase activity, oxidation-reduction process4.85e-02*aox1fbgn0267408aldehyde oxidase, Pyridoxal oxidase activity5.82e-03**cyt-b5fbgn0264294cytocrome B5-like Heme-Binding Site6.47e-04***cyp313a1fbgn0038236cytochrome P450, Heme and Iron Ion binding, Oxidation-reduction process1.45e-02*mt: coifbgn0013674mitochondrial Cytochrome C oxidase, Heme and iron binding7.39e-02.aldhfbgn0012036aldehyde dehydrogenase, oxidation-reduction9.39e-03**Cyp4E3Fbgn0015035Cytochrome P450, Heme and Iron Ion binding, oxidation-reduction process1.27e-05***hgofbgn0040211homogentisate 1, 2-Dioxygenase activity, Oxidation-reduction process4.08e-03**Pdhfbgn0011693Retinol and Alcohol dehydrogenase activity, Oxidation-reduction process4.75e-03**desat1fbgn0086687fatty Acid desaturase, Oxidation-reduction process2.55e-05***plodfbgn0036147iron Ion binding, oxidoreductase activity, oxidation-reduction process6.75e-04***fad2fbgn0029172fatty Acid desaturase, oxidation-reduction process, Lipid Metabolic Process1.15e-03**gpdhfbgn0001128carbohydrate Metabolic Process, oxidation-reduction process6.13e-04***goterm_bp/cc/mf_directcalcium Ion channel, Transmembrane transport2.13trplfbgn0005614calcium channel activity, calcium Ion transport2.13e-02*trpfbgn0003861plasma Membrane Cation channel, calcium channel3.06e-09***goterm_bp/cc/mf_directvoltage-gated potassium channel activity2.03irk3fbgn0032706potassium channel activity, potassium Ion transport3.88e-02*kegg_pathway, interpro, goterm_bp/cc/mf_directfatty Acid Metabolism/biosynthetic process1.93accfbgn0033246acetyl-coa carboxylase activity, Fatty Acid Biosybthetic process3.44e-03**cyt-b5-rfbgn0000406cytochrome B5-like Heme binding, Lipid Metabolic Process6.47e-04***desat1fbgn0086687fatty Acid desaturase, oxidation-reduction process2.55e-05***fad2fbgn0029172fatty Acid desaturase, oxidation-reduction process, Lipid Metabolic Process1.15e-03**acslfbgn0263120long-Chain Fatty Acid-Coa ligase activity1.03e-04***interpro, goterm_mf_directcarbohydrate binding1.91clect27fbgn0031629carbohydrate binding4.40e-11***lectin-37dbfbgn0053533galactose binding2.68e-04***interpro, goterm_mf_directpotassium Ion Transport, Oxalate Transmembrane transporter activity1.65irk3fbgn0032706potassium channel activity, potassium Ion transport3.88e-02*irk2fbgn0039081potassium channel activity, potassium Ion transport1.96e-08***dic1fbgn0027610inorganic Phosphate Transmembrane transporter activity3.33e-05***goterm_mf/bp/cc_direct, interproneurotransmitter-gated Ion-channel ligand binding1.45calsfbgn0039928calcium Ion binding2.29e-02*goterm_mf/bp/cc_direct, interpro, cog_ontologyreceptor activity, carboxylesterase, Lipid Metabolism1.35alpha-est7fbgn0015575carboxylic Ester hydrolase activity, Lipid Storage, determination of Lifespan2.49e-04***accfbgn0033246acetyl-coa carboxylase activity, Fatty Acid Biosybthetic Process3.44e-03**gs2fbgn0001145glutamate Catabolic Process, Neurotransmitter receptor Metabolic process1.46e-03**est-6fbgn0000592carboxylic Ester hydrolase activity2.93e-02*accoasfbgn0012034acetyl-coa ligase activity3.35e-04***goterm_mf/bp/cc_direct, interproneurotransmitter transporter1.32naat1fbgn0029762neurotransmitter transporter activity2.06e-08***eaat1fbgn0026439glutamate: sodium symporter activity, determination of Adult Lifespan2.06e-02*\nGenes that were significantly down-regulated in these data in hplc compared to lphc were compared to a background list of Genes that were Expressed and detected in these data.']	N/A	N/A	[('SO_0000704', 'gene', 143, 'gene'), ('SO_0000417', 'polypeptide_domain', 225, 'domain'), ('SO_0000417', 'polypeptide_domain', 291, 'domain'), ('GO_0031012', 'extracellular matrix', 299, 'extracellular matrix'), ('GO_0006508', 'proteolysis', 524, 'proteolysis0'), ('GO_0006412', 'translation', 894, 'proteolysis5'), ('GO_0006412', 'translation', 958, 'proteolysis1'), ('GO_0006412', 'translation', 1022, 'proteolysis5'), ('PR_000015393', 'suppressor of cytokine signaling 2', 1043, 'SwimFBgn0034709Polysaccharide'), ('GO_0006412', 'translation', 1116, 'proteolysis1'), ('GO_0006412', 'translation', 1180, 'proteolysis1'), ('GO_0006952', 'defense response', 1265, 'defense'), ('GO_0006412', 'translation', 1338, 'proteolysis1'), ('GO_0006508', 'proteolysis', 1407, 'proteolysis6'), ('GO_0006412', 'translation', 1567, 'proteolysis8'), ('PR_000013940', 'repulsive guidance molecule A', 1669, 'rhodopsin-like6'), ('CL_0000210', 'photoreceptor cell', 1719, 'photoreceptor'), ('CHEBI_18059', 'lipid', 1781, 'lipid'), ('CHEBI_17855', 'triglyceride', 1791, 'tryglyceride'), ('GO_0042592', 'homeostatic process', 1804, 'homeostasis1'), ('CL_0000210', 'photoreceptor cell', 1858, 'photoreceptor'), ('GO_0007416', 'synapse assembly', 1937, 'synaptic transmission1'), ('GO_0045202', 'synapse', 1937, 'synaptic'), ('PR_000011271', 'NACHT, LRR and PYD domains-containing protein 3', 1969, 'ninaEFBgn0002940G'), ('CL_0000210', 'photoreceptor cell', 2003, 'photoreceptor'), ('PR_000001855', 'fractalkine', 2027, 'rhodopsin-like2'), ('PR_000014700', 'serpin B9', 2072, 'protein, gamma subunit'), ('PR_000035364', 'histone H3-like centromeric protein A, initiator methionine removed phosphorylated 1 (human)', 2133, 'Gbeta76CFBgn0004623G'), ('CL_0000210', 'photoreceptor cell', 2170, 'photoreceptor'), ('CL_0000210', 'photoreceptor cell', 2233, 'photoreceptor'), ('CHEBI_37527', 'acid', 2304, 'acid'), ('CHEBI_37527', 'acid', 2344, 'acid'), ('GO_0023051', 'regulation of signaling', 2454, 'signaling'), ('GO_0003017', 'lymph circulation', 2465, 'humoral immune response1'), ('UBERON_0002405', 'immune system', 2473, 'immune'), ('GO_0065007', 'biological regulation', 2612, 'regulation'), ('CHEBI_16247', 'phospholipid', 2681, 'phospholipid'), ('CHEBI_24870', 'ion', 2729, 'ion'), ('CHEBI_16247', 'phospholipid', 2760, 'phospholipid'), ('CHEBI_24870', 'ion', 2838, 'ion'), ('SO_0000417', 'polypeptide_domain', 2880, 'domain2'), ('CHEBI_24870', 'ion', 2912, 'ion'), ('GO_0007608', 'sensory perception of smell', 2934, 'synaptic transmission2'), ('GO_0045202', 'synapse', 2934, 'synaptic'), ('CHEBI_39124', 'calcium ion', 2993, 'calcium ion'), ('PR_000029773', 'ankyrin repeat domain-containing protein SOWAHB', 3022, 'Scp2FBgn0020907Calcium'), ('CHEBI_24870', 'ion', 3045, 'ion'), ('PR_000029775', 'histidine--tRNA ligase, mitochondrial', 3065, 'Scp1FBgn0020908Calcium'), ('CHEBI_24870', 'ion', 3088, 'ion'), ('CHEBI_24870', 'ion', 3131, 'ion'), ('CHEBI_18059', 'lipid', 3232, 'lipids'), ('CHEBI_39124', 'calcium ion', 3257, 'calcium ion'), ('CHEBI_24870', 'ion', 3309, 'ion'), ('CHEBI_24870', 'ion', 3360, 'ion'), ('CHEBI_39124', 'calcium ion', 3373, 'calcium ion'), ('GO_0000278', 'mitotic cell cycle', 3398, 'muscle morphogenesis3'), ('PR_000021909', 'TGF-beta 2 isoform B, signal peptide removed form', 3429, 'TpnC73FFBgn0010424Calcium'), ('CHEBI_24870', 'ion', 3455, 'ion'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 3477, 'Gpo'), ('CHEBI_15588', '(R)-malate(2-)', 3501, '-3-phosphate'), ('CHEBI_39124', 'calcium ion', 3538, 'calcium ion'), ('CHEBI_17984', 'acyl-CoA', 3606, 'acyl-CoA'), ('GO_0005777', 'peroxisome', 3626, 'peroxisome2'), ('GO_0009056', 'catabolic process', 3792, 'catabolic process'), ('CHEBI_8756', 'RNA (poly(A))', 3878, 'ROS'), ('GO_0006401', 'RNA catabolic process', 3878, 'ROS metabolic process1'), ('GO_0045732', 'positive regulation of protein catabolic process', 3946, 'oxidation-'), ('GO_0005777', 'peroxisome', 3975, 'peroxisome1'), ('CHEBI_35366', 'fatty acid', 4047, 'fatty acid'), ('GO_0006635', 'fatty acid beta-oxidation', 4047, 'fatty acid beta-oxidation'), ('GO_0005777', 'peroxisome', 4074, 'peroxisome4'), ('CHEBI_24870', 'ion', 4163, 'iron ion'), ('CHEBI_4056', 'cytochrome', 4181, 'Cytochrome'), ('UBERON_0007023', 'adult organism', 4252, 'adult'), ('UBERON_0000104', 'life cycle', 4258, 'lifespan5'), ('CHEBI_30413', 'heme', 4312, 'heme'), ('CHEBI_24870', 'ion', 4321, 'iron ion'), ('PR_000001900', 'neuropilin-1', 4404, 'P450'), ('CHEBI_30413', 'heme', 4410, 'heme'), ('CHEBI_24870', 'ion', 4419, 'iron ion'), ('GO_0045732', 'positive regulation of protein catabolic process', 4525, 'oxidation-'), ('CHEBI_18059', 'lipid', 4621, 'lipid'), ('GO_0002449', 'lymphocyte mediated immunity', 4621, 'lipid metabolic process2'), ('PR_000029120', 'cGMP-dependent protein kinase 1', 4655, 'antdhFBgn0026268Oxidoreductase'), ('CHEBI_17310', 'pyridoxal', 4765, 'pyridoxal'), ('PR_000002118', 'voltage-dependent P/Q-type calcium channel subunit alpha-1A', 4828, 'b5'), ('CHEBI_30413', 'heme', 4836, 'heme'), ('SO_0000409', 'binding_site', 4841, 'binding site6'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 4894, 'P450'), ('PR_000001900', 'neuropilin-1', 4894, 'P450'), ('CHEBI_30413', 'heme', 4900, 'heme'), ('CHEBI_24870', 'ion', 4909, 'iron ion'), ('GO_0045732', 'positive regulation of protein catabolic process', 4927, 'oxidation-'), ('CHEBI_18070', 'cytochrome c', 4995, 'Cytochrome C'), ('PR_000006035', 'cathepsin Z', 4995, 'Cytochrome C'), ('CHEBI_30413', 'heme', 5017, 'heme'), ('PR_000027147', 'cyclin B1:Cdk1 complex phosphorylated 5 (human)', 5115, 'Cyp4e3FBgn0015035Cytochrome P450'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 5143, 'P450'), ('CHEBI_30413', 'heme', 5149, 'heme'), ('CHEBI_24870', 'ion', 5158, 'iron ion'), ('CHEBI_50971', '[4]pseudorotaxane', 5247, 'dioxygenase'), ('GO_0015671', 'oxygen transport', 5269, 'oxidation'), ('PR_000001655', 'prostacyclin receptor', 5306, 'PdhFBgn0011693Retinol'), ('CHEBI_30879', 'alcohol', 5332, 'alcohol'), ('GO_0015671', 'oxygen transport', 5364, 'oxidation'), ('CHEBI_37527', 'acid', 5424, 'acid'), ('GO_0045732', 'positive regulation of protein catabolic process', 5441, 'oxidation-'), ('CHEBI_24870', 'ion', 5499, 'ion'), ('CHEBI_37527', 'acid', 5596, 'acid'), ('CHEBI_18059', 'lipid', 5642, 'lipid'), ('GO_0010352', 'lithium ion export across the plasma membrane', 5642, 'lipid metabolic process1'), ('GO_0008152', 'metabolic process', 5703, 'metabolic process'), ('CHEBI_24870', 'ion', 5790, 'ion'), ('GO_0042651', 'thylakoid membrane', 5803, 'transmembrane'), ('CHEBI_24870', 'ion', 5879, 'ion'), ('GO_0016020', 'membrane', 5922, 'membrane'), ('CHEBI_36916', 'cation', 5931, 'cation'), ('CHEBI_24870', 'ion', 6092, 'ion'), ('CHEBI_37527', 'acid', 6166, 'acid'), ('GO_0043443', 'acetone metabolic process', 6166, 'acid metabolism'), ('CHEBI_35366', 'fatty acid', 6253, 'fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 6253, 'fatty acid biosybthetic'), ('PR_000002118', 'voltage-dependent P/Q-type calcium channel subunit alpha-1A', 6324, 'b5'), ('CHEBI_30413', 'heme', 6332, 'heme'), ('CHEBI_18059', 'lipid', 6346, 'lipid'), ('GO_0006629', 'lipid metabolic process', 6346, 'lipid metabolic process6'), ('CHEBI_37527', 'acid', 6403, 'acid'), ('CHEBI_37527', 'acid', 6479, 'acid'), ('CHEBI_18059', 'lipid', 6525, 'lipid'), ('GO_0010352', 'lithium ion export across the plasma membrane', 6525, 'lipid metabolic process1'), ('CHEBI_80086', 'Onnamide A', 6577, '-chain fatty acid-CoA'), ('CHEBI_24870', 'ion', 6810, 'ion'), ('GO_0006811', 'ion transport', 6810, 'ion transport'), ('CHEBI_16162', 'o-orsellinate', 6825, 'oxalate'), ('GO_0009294', 'DNA mediated transformation', 6833, 'transmembrane'), ('GO_0042651', 'thylakoid membrane', 6833, 'transmembrane'), ('CHEBI_24870', 'ion', 6924, 'ion'), ('CHEBI_24870', 'ion', 6999, 'ion'), ('CHEBI_18367', 'phosphate(3-)', 7048, 'phosphate'), ('GO_0042651', 'thylakoid membrane', 7058, 'transmembrane'), ('CHEBI_24870', 'ion', 7158, 'ion'), ('CHEBI_24870', 'ion', 7211, 'ion'), ('CHEBI_18059', 'lipid', 7314, 'lipid'), ('GO_0002088', 'lens development in camera-type eye', 7314, 'lipid metabolism1'), ('CHEBI_35701', 'ester', 7366, 'ester'), ('CHEBI_18059', 'lipid', 7392, 'lipid'), ('GO_0019915', 'lipid storage', 7392, 'lipid storage'), ('UBERON_0000104', 'life cycle', 7424, 'lifespan2'), ('CHEBI_35366', 'fatty acid', 7490, 'fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 7490, 'fatty acid biosybthetic process3'), ('GO_0009056', 'catabolic process', 7555, 'catabolic process'), ('CHEBI_25512', 'neurotransmitter', 7574, 'neurotransmitter'), ('GO_0008152', 'metabolic process', 7600, 'metabolic'), ('CHEBI_35701', 'ester', 7654, 'ester'), ('UBERON_0007023', 'adult organism', 7940, 'adult'), ('UBERON_0000104', 'life cycle', 7946, 'lifespan2'), ('SO_0000704', 'gene', 7964, 'Genes'), ('SO_0000704', 'gene', 8086, 'genes'), ('GO_0010467', 'gene expression', 8102, 'expressed')]
S38-PMC4630792	PMC4630792	11/2015	S38-PMC4630792	['oxidative stress, Ageing and anti-oxidant Defense mechanisms\nlevels of 4-Hne (4-Hydroxy-Nonenal; a marker of Lipid peroxidation, reflecting oxidative stress levels) were significantly increased in the Ovarian Tissue of the recuperated Animals compared to the control group at 6 months of age (p\u2009<\u20090.001) (fig.']	N/A	N/A	[('GO_0007568', 'aging', 18, 'ageing'), ('GO_0006952', 'defense response', 42, 'defense'), ('CHEBI_72639', '13-HODE', 71, '4-HNE'), ('CHEBI_58968', '(E)-4-hydroxynon-2-enal', 78, '4-hydroxy-nonenal'), ('CHEBI_18059', 'lipid', 109, 'lipid'), ('UBERON_0000992', 'ovary', 201, 'ovarian'), ('UBERON_0000479', 'tissue', 209, 'tissue'), ('NCBITaxon_33208', 'Metazoa', 235, 'animals')]
S53-PMC4287506	PMC4287506	10/2014	S53-PMC4287506	['caption (table-wrap): table 1\n\noperational definitions of obstetric complication and near misses by type of Pregnancy outcomecategoryobstetric complicationnear miss Live Births or stillbirths - complications during Deliverypostpartum hemorrhage report of profuse bleeding or retained Placentareport of nearly dying\u2009+\u2009profuse bleedingsensitivity: 63-84%, specificity: 89-97% eclampsia convulsions (excluding epilepsy) and no high feverreport of nearly dying\u2009+\u2009convulsions (excluding epilepsy) and no high feversensitivity: 73-99%, specificity: 86-99% sepsis high fever\u2009+\u2009foul-smelling vaginal discharge or high fever\u2009+\u2009Lower Abdominal painreport of nearly dying\u2009+\u2009high feversensitivity: 69-74%, specificity: 95-98% obstructed labor (report of baby stuck\u2009+\u2009use of Saline drip with injection) or (report of baby stuck\u2009+\u2009injection only) or labor pains >24\xa0hoursreport of nearly dying\u2009+\u2009(report of baby stuck\u2009+\u2009use of Saline drip with injection) or (report of baby stuck\u2009+\u2009injection only) or Labor pains >24\xa0hourssensitivity: 56-70%, specificity: 99-100% induced Abortions or Miscarriagescategoryobstetric complicationnear misshemorrhage report of Vaginal bleeding (other than spotting) heavier than a normal period in 72\xa0hours following Pregnancy outcomereport of nearly dying\u2009+\u2009profuse bleeding sepsis high fever\u2009+\u2009foul-smelling vaginal discharge or high fever\u2009+\u2009lower Abdominal pain in 7\xa0days after Pregnancy outcomereport of nearly dying\u2009+\u2009high fever\ncaption: these definitions are based on who’s integrated management of Pregnancy and Childbirth guidelines [51].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('GO_0007618', 'mating', 165, 'Live'), ('GO_0007567', 'parturition', 170, 'Births'), ('GO_0006952', 'defense response', 215, 'deliveryPostpartum'), ('UBERON_0034878', 'prechordal mesoderm', 284, 'placentaReport'), ('UBERON_0002200', 'vasculature of head', 618, 'lower abdominal'), ('CHEBI_24866', 'salt', 762, 'saline'), ('CHEBI_24866', 'salt', 913, 'saline'), ('GO_0007612', 'learning', 987, 'labor'), ('GO_0006915', 'apoptotic process', 1058, 'abortions'), ('GO_0007475', 'apposition of dorsal and ventral imaginal disc-derived wing surfaces', 1071, 'miscarriagesCategoryObstetric'), ('UBERON_0001987', 'placenta', 1143, 'vaginal'), ('GO_0007565', 'female pregnancy', 1233, 'pregnancy'), ('UBERON_0000916', 'abdomen', 1366, 'abdominal'), ('GO_0007565', 'female pregnancy', 1397, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1521, 'Pregnancy'), ('GO_0007567', 'parturition', 1535, 'Childbirth')]
S132-PMC4483650	PMC4483650	6/2015	S132-PMC4483650	['there are several Defense systems in the Brain to protect against Ros, one of which is sod.']	N/A	N/A	[('GO_0006952', 'defense response', 18, 'defense'), ('UBERON_0000955', 'brain', 41, 'brain'), ('CHEBI_8756', 'RNA (poly(A))', 66, 'ROS')]
S57-PMC5523023	PMC5523023	7/2017	S57-PMC5523023	['Ros and Rns, insufficient function of antioxidant Defense mechanisms and oxidation of the Biomolecules have many consequences, such as enhanced Release Of arachidonic Acid From Cell Membranes and Formation of Inflammatory markers, hyperreactivity and Contraction Of Airway Smooth Muscle, increased vascular permeability with Airway edema, increased Bronchial hyperresponsiveness and Mucus secretion, increased synthesis of pro-inflammatory cytokines and chemoattractants, induced release of tachykinins and neurokinins with augmentation of Neurogenic inflammation, and impaired response to bronchodilators (figure2) (8,11,16).']	N/A	N/A	[('CHEBI_8756', 'RNA (poly(A))', 0, 'ROS'), ('CHEBI_18313', 'alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide', 8, 'RNS'), ('GO_0006952', 'defense response', 50, 'defense'), ('CHEBI_62415', 'propanoyl-AMP', 90, 'biomolecules'), ('GO_0097396', 'response to interleukin-17', 144, 'release of ... acid from'), ('GO_0005886', 'plasma membrane', 177, 'cell membranes'), ('GO_0007613', 'memory', 182, 'membranes'), ('GO_0009057', 'macromolecule catabolic process', 196, 'formation'), ('GO_0007631', 'feeding behavior', 209, 'inflammatory'), ('GO_0046895', 'N-terminal peptidyl-isoleucine methylation', 251, 'contraction of airway smooth muscle'), ('UBERON_0001005', 'respiratory airway', 266, 'airway'), ('UBERON_0001135', 'smooth muscle tissue', 273, 'smooth muscle'), ('UBERON_0001005', 'respiratory airway', 325, 'airway'), ('UBERON_0002186', 'bronchiole', 349, 'bronchial'), ('UBERON_0000912', 'mucus', 383, 'mucus'), ('GO_0001822', 'kidney development', 540, 'neurogenic')]
S15-PMC5372327	PMC5372327	3/2017	S15-PMC5372327	['locally produced Calcitriol in Immune Cells participates in host Defence reactions and acts as a potent immunomodulator [2,5].']	N/A	N/A	[('CHEBI_17823', 'calcitriol', 17, 'calcitriol'), ('CL_0000738', 'leukocyte', 31, 'immune cells'), ('UBERON_0002405', 'immune system', 31, 'immune'), ('GO_0006952', 'defense response', 65, 'defence')]
S42-PMC4258799	PMC4258799	11/2014	S42-PMC4258799	['furthermore, mature Spermatozoa lack Cytoplasmic enzymes and antioxidant Defense mechanisms [17].']	N/A	N/A	[('CL_0000019', 'sperm', 20, 'spermatozoa'), ('GO_0005737', 'cytoplasm', 37, 'cytoplasmic'), ('GO_0006952', 'defense response', 73, 'defense')]
S275-PMC4258799	PMC4258799	11/2014	S275-PMC4258799	['Superoxide dismutase\nIsoforms of sod found in Mitochondria (manganese sod) and Cytoplasm (copper/zinc sod) provide fundamental Defense against Ros [136].']	N/A	N/A	[('CHEBI_9358', 'Sumatrol', 0, 'Superoxide'), ('SO_0001060', 'sequence_variant', 21, 'Isoforms'), ('GO_0005739', 'mitochondrion', 46, 'mitochondria'), ('GO_0005737', 'cytoplasm', 79, 'cytoplasm'), ('GO_0006952', 'defense response', 127, 'defense'), ('CHEBI_8756', 'RNA (poly(A))', 143, 'ROS')]
S17-PMC2779500	PMC2779500	11/2009	S17-PMC2779500	['at normal Ros concentrations, cell function and structure are protected from destructive interactions with Ros by various Defence mechanisms.']	N/A	N/A	[('CHEBI_8756', 'RNA (poly(A))', 10, 'ROS'), ('CHEBI_8756', 'RNA (poly(A))', 107, 'ROS'), ('GO_0006952', 'defense response', 122, 'defence')]
S51-PMC3403156	PMC3403156	7/2012	S51-PMC3403156	"[""Generation Of Oxidative Stress\noxidative Stress occurs when the generation of reactive oxidant Molecules exceeds the capacity of the cell's antioxidant Defense mechanisms.""]"	N/A	N/A	[('GO_0036005', 'response to macrophage colony-stimulating factor', 0, 'Generation of Oxidative Stress'), ('GO_0008380', 'RNA splicing', 41, 'stress'), ('CHEBI_36357', 'polyatomic entity', 95, 'molecules'), ('GO_0006952', 'defense response', 152, 'defense')]
S56-PMC3488908	PMC3488908	4/2010	S56-PMC3488908	['development of innate immune function\nAntigen-presenting cells and other cells of the innate Immune System provide the first line of Defense against pathogenic environmental exposures.']	N/A	N/A	[('CHEBI_59132', 'antigen', 38, 'Antigen'), ('GO_0007566', 'embryo implantation', 93, 'immune'), ('UBERON_0002405', 'immune system', 93, 'immune system'), ('GO_0006952', 'defense response', 133, 'defense')]
S256-PMC3586494	PMC3586494	2/2013	S256-PMC3586494	['many Micronutrients are antioxidants or are components of the antioxidant Defense system.']	N/A	N/A	[('CHEBI_33839', 'macromolecule', 5, 'micronutrients'), ('GO_0006952', 'defense response', 74, 'defense')]
S132-PMC3683620	PMC3683620	5/2013	S132-PMC3683620	['in the first minutes after a stressful event, Appetite is typically suppressed; a mechanism that discourages Food Seeking and Feeding when more pressing actions such as escape or Defense are more prudent.']	N/A	N/A	[('GO_0000239', 'pachytene', 46, 'appetite'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0006457', 'protein folding', 109, 'food seeking'), ('GO_0007631', 'feeding behavior', 126, 'feeding'), ('GO_0006952', 'defense response', 179, 'defense')]
S151-PMC4172064	PMC4172064	9/2014	S151-PMC4172064	['the key mechanism involves Viral triggered Upregulation Of Fcer1-Expression on local Airway Mucosal (Am) Dc that results in recruitment of “bystander” Aeroallergen-specific Th2-Memory Responses into the inflammatory milieu at the infection site, which in turn attenuates th1-dependent anti-Viral Defense mechanisms and delays Viral clearance.']	N/A	N/A	[('NCBITaxon_1', 'root', 27, 'viral'), ('GO_0010628', 'positive regulation of gene expression', 43, 'upregulation of ... expression'), ('PR_000007440', 'Fc receptor-like protein 1', 59, 'FcER1'), ('UBERON_0001005', 'respiratory airway', 85, 'airway'), ('CL_0000187', 'muscle cell', 92, 'mucosal ...'), ('UBERON_0000344', 'mucosa', 92, 'mucosal'), ('CL_0002448', 'Ly49H-negative natural killer cell, mouse', 101, 'AM ... DC'), ('CHEBI_2500', 'Aescin', 151, 'aeroallergen'), ('GO_0043050', 'pharyngeal pumping', 173, 'Th2-'), ('GO_0007498', 'mesoderm development', 177, 'memory responses'), ('NCBITaxon_1', 'root', 290, 'viral'), ('GO_0006952', 'defense response', 296, 'defense'), ('NCBITaxon_1', 'root', 326, 'viral')]
S31-PMC4258799	PMC4258799	11/2014	S31-PMC4258799	['both Male and Female Reproductive Systems possess antioxidant Defense mechanisms that facilitate the quenching of Ros, and maintain equilibrium between pro- and anti-Oxidants.']	N/A	N/A	[('GO_0007618', 'mating', 5, 'male'), ('GO_0007631', 'feeding behavior', 14, 'female'), ('GO_0000302', 'response to reactive oxygen species', 21, 'reproductive systems'), ('UBERON_0000990', 'reproductive system', 21, 'reproductive systems'), ('GO_0006952', 'defense response', 62, 'defense'), ('CHEBI_8756', 'RNA (poly(A))', 114, 'ROS'), ('CHEBI_63248', 'oxidising agent', 166, 'oxidants')]
S70-PMC4392531	PMC4392531	3/2015	S70-PMC4392531	['[1011] the underlying cause of oxidative stress is an imbalance in Free Radicals and the antioxidant Defense system.']	N/A	N/A	[('CHEBI_26519', 'radical', 67, 'free radicals'), ('GO_0006952', 'defense response', 101, 'defense')]
S42-PMC4630792	PMC4630792	11/2015	S42-PMC4630792	['anti-oxidant Defense mechanisms were also examined (table 2).']	N/A	N/A	[('GO_0006952', 'defense response', 13, 'defense')]
S62-PMC4703052	PMC4703052	1/2016	S62-PMC4703052	['costs of Immunity\nthe costs of Immunity are substantial, variable across subsystems of Defense, and shaped by local ecological conditions.']	N/A	N/A	[('GO_0007566', 'embryo implantation', 9, 'immunity'), ('GO_0007566', 'embryo implantation', 31, 'immunity'), ('GO_0006952', 'defense response', 87, 'defense')]
S12-PMC4859539	PMC4859539	5/2016	S12-PMC4859539	['primarily utilized by Monocytes, Macrophages, Mucosal Epithelial Cells, and Keratinocytes as part of the innate Immune System, these cells release Cathelicidin along with other cytokines and Signal Molecules as a first line of Defense [5].']	N/A	N/A	[('CL_0000576', 'monocyte', 22, 'monocytes'), ('CL_0000235', 'macrophage', 33, 'macrophages'), ('CL_0002365', 'medullary thymic epithelial cell', 46, 'mucosal epithelial cells'), ('UBERON_0004980', 'mucosa of ureter', 46, 'mucosal epithelial'), ('CL_0000312', 'keratinocyte', 76, 'keratinocytes'), ('UBERON_0002405', 'immune system', 112, 'immune system'), ('PR_000006009', 'alpha-catulin', 147, 'cathelicidin'), ('CHEBI_62488', 'signalling molecule', 191, 'signal molecules'), ('GO_0006952', 'defense response', 227, 'defense')]
S188-PMC4871475	PMC4871475	5/2016	S188-PMC4871475	['‘Urinating’ and ‘Defecating’ were pooled as ‘eliminating’.']	N/A	N/A	[('GO_0006370', '7-methylguanosine mRNA capping', 1, 'Urinating'), ('GO_0006952', 'defense response', 17, 'defecating')]
S41-PMC4910734	PMC4910734	6/2015	S41-PMC4910734	['most endogenous Aldehydes are quickly reduced, oxidized, or neutralized by the cellular antioxidant Defense system to prevent the random interactions with surrounding Biomolecules.']	N/A	N/A	[('CHEBI_17478', 'aldehyde', 16, 'aldehydes'), ('GO_0006952', 'defense response', 100, 'defense'), ('CHEBI_62415', 'propanoyl-AMP', 167, 'biomolecules')]
S19-PMC4997411	PMC4997411	8/2016	S19-PMC4997411	['fetal Immune function is easily disrupted because of an immature antioxidant Defense system.']	N/A	N/A	[('UBERON_0002405', 'immune system', 6, 'immune'), ('GO_0006952', 'defense response', 77, 'defense')]
S24-PMC4997411	PMC4997411	8/2016	S24-PMC4997411	['the antioxidant Defense system results in the health progression of all stages of follicle growth and the timing of the onset of Ovulation.']	N/A	N/A	[('GO_0006952', 'defense response', 16, 'defense'), ('GO_0030728', 'ovulation', 129, 'ovulation')]
S160-PMC4997411	PMC4997411	8/2016	S160-PMC4997411	['moreover, antioxidant Defense system damage and an increase in Free Radicals caused by high bf will lead to Feed Intake being reduced [21].']	N/A	N/A	[('GO_0006952', 'defense response', 22, 'defense'), ('CHEBI_26519', 'radical', 63, 'free radicals'), ('GO_0007631', 'feeding behavior', 108, 'feed'), ('GO_0007631', 'feeding behavior', 113, 'intake')]
S127-PMC5513133	PMC5513133	7/2017	S127-PMC5513133	['brazil 2015 [83]cross-sectional179 -- Pregnant women recruited before Deliverynear Deliverycase control studies\u2003abedi et al., iran, 2014 [84]case control59 – women with peat delivery59 – healthy Pregnant controls\u2003achkar et al., canada, 2015 [81]case control169 – women with pe<20\xa0weeks Gestation1975 – healthy Pregnant controls\u2003anderson et al., usa, 2015 [111]case control11 -- Gestational htn (10/11 with pe)at Delivery37 – healthy Pregnant controls\u2003baker et al., 2010 [80]nested case control51 – developed pe2nd trimester204 – healthy Pregnant controls\u2003bodnar et al., usa, 2007 [18]nested case control55 – developed pe<22\xa0weeks219 – healthy Pregnant controls\u2003bodnar et al., usa, 2014 [79]case control717 – developed pe<26\xa0weeks Gestation 560 mild; 157 severe 2986 – healthy \ufeffPregnant\ufeffcontrols\u2003gidlof s, et al.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('GO_0048513', 'animal organ development', 70, 'deliveryNear'), ('GO_0006952', 'defense response', 83, 'deliveryCase'), ('GO_0007565', 'female pregnancy', 195, 'pregnant'), ('GO_0035483', 'gastric emptying', 286, 'gestation1975'), ('GO_0007565', 'female pregnancy', 310, 'pregnant'), ('GO_0007565', 'female pregnancy', 378, 'gestational'), ('GO_0008206', 'bile acid metabolic process', 412, 'delivery37'), ('GO_0007565', 'female pregnancy', 433, 'pregnant'), ('GO_0007565', 'female pregnancy', 537, 'pregnant'), ('GO_0007565', 'female pregnancy', 643, 'pregnant'), ('GO_0007565', 'female pregnancy', 730, 'gestation'), ('GO_0007565', 'female pregnancy', 777, 'pregnant')]
S4-PMC5523023	PMC5523023	7/2017	S4-PMC5523023	['oxidative stress results from an imbalance between the Production Of Reactive Oxygen Species and Reactive Nitrogen Species and the capacity of antioxidant Defense mechanisms.']	N/A	N/A	[('GO_1903409', 'reactive oxygen species biosynthetic process', 55, 'production of reactive oxygen species'), ('CHEBI_26523', 'reactive oxygen species', 69, 'reactive oxygen species'), ('CHEBI_62764', 'reactive nitrogen species', 97, 'reactive nitrogen species'), ('GO_0022414', 'reproductive process', 97, 'reactive nitrogen species'), ('GO_0006952', 'defense response', 155, 'defense')]
S25-PMC5523023	PMC5523023	7/2017	S25-PMC5523023	['oxidative stress results from an imbalance between the Production Of pro-Oxidants (e.g., Ros or Rns) and antioxidant Defense mechanisms in the body.']	N/A	N/A	[('GO_0018980', '2,4,5-trichlorophenoxyacetic acid metabolic process', 55, 'production of ... oxidants'), ('CHEBI_63248', 'oxidising agent', 73, 'oxidants'), ('CHEBI_8756', 'RNA (poly(A))', 89, 'ROS'), ('CHEBI_18313', 'alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide', 96, 'RNS'), ('GO_0006952', 'defense response', 117, 'defense')]
S35-PMC5523023	PMC5523023	7/2017	S35-PMC5523023	['under physiological condition, antioxidant Defense mechanisms are able to eliminate and repair these changes.']	N/A	N/A	[('GO_0006952', 'defense response', 43, 'defense')]
S59-PMC5523023	PMC5523023	7/2017	S59-PMC5523023	['interplay between intrinsic and extrinsic factors leads to the Production Of Reactive Oxygen Species (Ros) and in certain conditions, due to the imbalance between the production of Ros and Antioxidant Defense, oxidative Stress and Modification Of Biomolecules develops.']	N/A	N/A	[('GO_1903409', 'reactive oxygen species biosynthetic process', 63, 'production of reactive oxygen species'), ('CHEBI_26523', 'reactive oxygen species', 77, 'reactive oxygen species'), ('CHEBI_8756', 'RNA (poly(A))', 102, 'ROS'), ('GO_0016246', 'RNA interference', 102, 'ROS'), ('CHEBI_8756', 'RNA (poly(A))', 181, 'ROS'), ('GO_0009051', 'pentose-phosphate shunt, oxidative branch', 189, 'antioxidant'), ('GO_0006952', 'defense response', 201, 'defense'), ('GO_0008380', 'RNA splicing', 220, 'stress'), ('GO_0061743', 'motor learning', 231, 'modification of'), ('CHEBI_62415', 'propanoyl-AMP', 247, 'biomolecules')]
S19-PMC5680205	PMC5680205	11/2017	S19-PMC5680205	['it is an essential element in more than 1000 proteins required for biological functions including antioxidant Defence, Cell Signalling and Gene Expression9–12.']	N/A	N/A	[('GO_0006952', 'defense response', 110, 'defence'), ('GO_0007267', 'cell-cell signaling', 119, 'cell signalling'), ('GO_0010467', 'gene expression', 139, 'gene expression9'), ('SO_0000704', 'gene', 139, 'gene')]
